Browse Arkansas Code titles and sections
17-96-205. Rules on Schedule II narcotics.
Arkansas Code — all titles (historical 2020) · legal_authorities
17-96-205. Rules on Schedule II narcotics.
The Arkansas Board of Podiatric Medicine shall adopt rules:
(1) Limiting the amount of Schedule II narcotics that may be prescribed and dispensed by licensees of the board; and
(2) Requiring licensees of the board to check the information in the Prescription Drug Monitoring Program as required under § 20-7-604(d)(2).
Source: Arkansas Code — historical release 78 (November 6, 2020) · 17-96-205
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:17-96-205
Source file: gov.ar.code.title.17.odt
Pages: Not recorded – Not recorded
Passage SHA-256: f1f9e1640cd889cf07b5c658f31d0cc22904ca6aa0d5b09e8dd99be85a322211
Source location: content.xml paragraph 29784
Stored source content
17-96-205. Rules on Schedule II narcotics.
The Arkansas Board of Podiatric Medicine shall adopt rules:
(1) Limiting the amount of Schedule II narcotics that may be prescribed and dispensed by licensees of the board; and
(2) Requiring licensees of the board to check the information in the Prescription Drug Monitoring Program as required under § 20-7-604(d)(2).
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Arkansas Code — all titles (historical 2020) · legal_authorities
20-7-604. Requirements for Prescription Drug Monitoring Program.
(a) The State Board of Health shall create the Prescription Drug Monitoring Program upon the Department of Health's procuring adequate funding to establish the program.
(b)(1) Each dispenser shall submit to the department information regarding each controlled substance dispensed.
(2) A dispenser located outside Arkansas and licensed and registered by the Arkansas State Board of Pharmacy shall submit to the department information regarding each controlled substance prescription dispensed to an ultimate user whose address is within Arkansas.
(3) The State Board of Health shall create a controlled substances database for the program.
(c) Each dispenser required to report under subsection (b) of this section shall submit to the department by electronic means information that shall include without limitation:
(1) The dispenser's identification number;
(2) The date the prescription was filled;
(3) The prescription number;
(4) Whether the prescription is new or is a refill;
(5) The National Drug Code for the controlled substance that is dispensed;
(6) The quantity of the controlled substance dispensed;
(7) The number of days' supply dispensed;
(8) The number of refills ordered;
(9)(A) A patient identifier.
(B) A patient identifier shall not be a Social Security number or a driver's license number;
(10) The patient's name;
(11) The patient's address;
(12) The patient's date of birth;
(13) The patient's gender;
(14) The prescriber's identification number;
(15) The date the prescription was issued by the prescriber; and
(16) The source of the payment for the prescription.
(d)(1) Except as required in subdivision (d)(2) of this section, practitioners are encouraged to acc
Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-7-604
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 20-7-604. This identifies an authority to review, not proof of applicability.